EPO-TEK 353ND PART B

Hazard statements (CLP)

H302, H314, H317, H318, H350, H360

Code

Statements

H302

Harmful if swallowed

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

Suspected of causing cancer. May damage fertility or the unborn child. Harmful if swallowed. Causes severe skin burns and eye damage. May cause an allergic skin reaction. Causes serious eye damage

Hazard pictograms

GHS05 GHS07 GHS08

Signal word

Danger

Contains

2-Ethyl-4-methyl-1H-imidazole-1-propanenitrile; imidazole; 1-methylimidazole; 4-Methyl-1H- imidazole; 2-Ethyl-4-methylimidazole

Hazard statements

H302 - Harmful if swallowed. H314 - Causes severe skin burns and eye damage. H317 - May cause an allergic skin reaction. H350 - May cause cancer. H360 - May damage fertility or the unborn child.

Precautionary statements

P101 - If medical advice is needed, have product container or label at hand. P102 - Keep out of reach of children. P103 - Read carefully and follow all instructions. P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P260 - Do not breathe dust/fume/gas/mist/vapours/spray.

Additional information

Restricted to professional users.

Other hazards which do not result in classification

Harmful dust may be released during cutting, milling or grinding process. Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH imidazole (288-32-4), 4-Methyl-1H-imidazole (822-36-6), 2-Ethyl-4-methylimidazole (931- regulation, in accordance with Annex XIII 36-2) Substance(s) not meeting the vPvB criteria of REACH imidazole (288-32-4), 4-Methyl-1H-imidazole (822-36-6), 2-Ethyl-4-methylimidazole (931- regulation, in accordance with Annex XIII 36-2) The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity (oral), Category 4 H302 Skin corrosion/irritation, Category 1, Sub-Category 1B H314 Serious eye damage/eye irritation, Category 1 H318 Skin sensitisation, Category 1 H317 Carcinogenicity, Category 1B H350 Reproductive toxicity, Category 1B H360 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects Suspected of causing cancer. May damage fertility or the unborn child. Harmful if swallowed. Causes severe skin burns and eye damage. May cause an allergic skin reaction. Causes serious eye damage.